OriGynMED raises $15.3m in Series B financing
The round was led by Sequoia Capital, with participation from its founding investor Eight Roads.

The proceeds will go towards ramping up its research and development (R&D) capabilities, business expansion, medical education, and marketing, as well as promotion and talent development.

Founded in 2015, OriGynMED provides overall solutions and cost-effective innovative products for healthcare niches. The company plans to launch a first gynecology innovative medical device product portfolio in 2021, and initiate a national clinical medical education and training program centered on minimally invasive gynecological surgery.